Sutro Biopharma Inc - KOL Discussion Of STRO-002 Data Transcript
Good afternoon, and welcome to the Sutro Biopharma KOL discussion of STRO-002 data virtual event. (Operator Instructions) Please be advised this call is being recorded at the company's request and will be available on the company's website for at least 30 days.
Now at this time, I would like to turn the call over to Ed Albini, Chief Financial Officer at Sutro Biopharma. Sir, please go ahead.
Thank you, operator. Good afternoon, everyone, and thank you for joining us. With me on the call are Bill Newell, Chief Executive Officer; Dr. Arturo Molina, Chief Medical Officer; Dr. Trevor Hallam, Chief Scientific Officer; Linda Fitzpatrick, Chief People and Communications Officer; and Annie Chang, Head of Investor Relations. We also welcome on the line Dr. Lainie P. Martin of the Hospital of the University of Pennsylvania and Dr. R. Wendel Naumann of the Levine Cancer Institute at Atrium Health.
This afternoon, we issued a news release that you can find on our website at sutrobio.com, which
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
